Tag:
calcitonin
Latest Headlines
Latest Headlines
Novartis falls short in trial for oral osteoporosis drug
Novartis Pharma's ( $NVS ) oral formulation of calcitonin to treat for post-menopausal osteoporosis failed to meet its primary endpoint or key secondary endpoints in a crucial critical trial....
DMC: Novartis' drug safe but not effective in mid-study analysis
An independent data monitoring committee (DMC) has weighed in on Novartis and Nordic Biosciences' Phase III study of oral calcitonin for the treatment of osteoarthritis of the knee. After analyzing a
